This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Bracco Imaging S.p.a., Bracco Suisse Sa. Active years: 2020-2022.
Location History:
- Prévessin-Moëns, FR (2020)
- Prevessin-Moens, FR (2022)
Company Filing History:
Years Active: 2020-2022
Title: Anthony Clouet: Innovator in Peptide-Phospholipid Conjugates
Introduction
Anthony Clouet is a notable inventor based in Prévessin-Moëns, France. He has made significant contributions to the field of peptide-phospholipid conjugates, holding 2 patents that showcase his innovative approach to therapeutic and diagnostic compositions.
Latest Patents
One of his latest patents is titled "Optimized process for dimeric peptide-phospholipid conjugate." This invention discloses a new efficient process for the preparation of the KDR-targeting peptide-phospholipid conjugate, which can be useful in therapeutic and diagnostic compositions, particularly in the preparation of ultrasound contrast agents. Another significant patent is "Solid phase synthesis of NIR fluorescent probe." This invention reveals a solid-phase process for the preparation of a Near Infra-Red (NIR) fluorescent probe characterized by an aza-bicycloalkane based cyclic peptide labeled with a Cy5.5 dye moiety, which is used in the guided surgery of tumors and pathologic regions.
Career Highlights
Throughout his career, Anthony Clouet has worked with prominent companies such as Bracco Suisse SA and Bracco Imaging S.p.A. His work in these organizations has allowed him to develop and refine his innovative ideas in the field of medical imaging and therapeutic applications.
Collaborations
Anthony has collaborated with notable professionals in his field, including Luciano Lattuada and Raphael Campanella. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Anthony Clouet is a distinguished inventor whose work in peptide-phospholipid conjugates has the potential to significantly impact therapeutic and diagnostic practices. His innovative patents and collaborations highlight his commitment to advancing medical technology.